Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients
β Scribed by Miller, C B; Waller, E K; Klingemann, H G; Dignani, M C; Anaissie, E J; Cagnoni, P J; McSweeney, P; Fleck, P R; Fruchtman, S M; McGuirk, J
- Book ID
- 110014070
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 143 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Early renal dysfunction following liver transplantation is associated with increased morbidity and mortality. To evaluate the impact of delayed initiation of calcineurin inhibitor on renal function, we conducted a retrospective study comparing 118 liver transplant recipients who received rabbit anti
Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n